Figure 4. LIFR-AS1 interacts with miR-197-3p in breast cancer cells.
(A) A putative binding site of miR-197-3p in LIFR-AS1 was predicted by miRanda algorithms. (B) Anti-Ago2 RIP was carried out to enrich the RNAs interacting with LIFR-AS1 in MCF7 cells after treatment with negative control or LIFR-AS1 mimics. (C) MiR-197-3p expression levels were determined by qRT-PCR after treatment with LIFR-AS1 mimics or siLIFR-AS1. ***P<0.001.